(Q40262886)

19 September 2017

title

Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. (English)

1 reference

19 September 2017

1 reference

1

1 reference

19 September 2017

7

Wilko Weichert

0 references

Aurelia Noske

series ordinal

4

object named as

Aurelia Noske

0 references

Silvia Niesporek

series ordinal

5

object named as

Silvia Niesporek

1 reference

19 September 2017

6

Manfred Dietel

1 reference

19 September 2017

Ines Koch

2

1 reference

19 September 2017

Nora von Keyserlingk

series ordinal

3

1 reference

19 September 2017

language of work or name

1 reference

23 June 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

19

1 reference

19 September 2017

issue

9

1 reference

19 September 2017

page(s)

1261-1269

1 reference

19 September 2017

cites work

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

DNA methylation: an alternative pathway to cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Expression genetics in cancer: shifting the focus from DNA to RNA.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Why is Hu where? Shuttling of early-response-gene messenger RNA subsets

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

HuR, a novel target of anti-Hu antibodies, is expressed in non-neural tissues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

The role of elav-like genes, a conserved family encoding RNA-binding proteins, in growth and development

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Role of the RNA-binding protein HuR in colon carcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

The 3'-UTR of the mRNA coding for the major protein kinase C substrate MARCKS contains a novel CU-rich element interacting with the mRNA stabilizing factors HuD and HuR.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

IL-1beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3' untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Increased expression of cyclooxygenase-2 to -1 in human colorectal cancers and adenomas, but not in hyperplastic polyps

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Aspirin use and reduced risk of fatal colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II)

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800645

7 January 2021

10.1038/MODPATHOL.3800645

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

1052427776

0 references

1 reference